ZYMEWORKS INC. Increase (Decrease) in Income Taxes Payable
ZYMEWORKS INC. (ZYME) reported Increase (Decrease) in Income Taxes Payable of -$38.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable · last filed 2026-08-06
- ZYMEWORKS INC. increase (decrease) in income taxes payable for the quarter ending 2026-06-30 was -$22.00K.
- ZYMEWORKS INC. increase (decrease) in income taxes payable for the quarter ending 2026-03-31 was -$16.00K.
- ZYMEWORKS INC. increase (decrease) in income taxes payable for the quarter ending 2025-12-31 was -$933.00K.
- ZYMEWORKS INC. increase (decrease) in income taxes payable for the quarter ending 2025-09-30 was $915.00K, a 567.88% increase year-over-year.
- ZYMEWORKS INC. increase (decrease) in income taxes payable for fiscal 2025 was -$45.00K.
- ZYMEWORKS INC. increase (decrease) in income taxes payable for fiscal 2024 was -$1.68M, a 273.40% decline from fiscal 2023.
- ZYMEWORKS INC. increase (decrease) in income taxes payable for fiscal 2023 was $970.00K, a 15.48% increase from fiscal 2022.
- ZYMEWORKS INC. increase (decrease) in income taxes payable for fiscal 2022 was $840.00K.
| Period end | Increase (Decrease) in Income Taxes Payable 3 month | Increase (Decrease) in Income Taxes Payable 6 month | Increase (Decrease) in Income Taxes Payable 9 month | Increase (Decrease) in Income Taxes Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$22.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$38.00K 10-Q · filed 2026-08-06 | -$971.00K derived: sum of 3 quarters · filed 2026-08-06 | -$56.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$16.00K 10-Q · filed 2026-05-07 | -$949.00K derived: sum of 2 quarters · filed 2026-05-07 | -$34.00K derived: sum of 3 quarters · filed 2026-05-07 | -$60.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$933.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$18.00K derived: sum of 2 quarters · filed 2026-03-02 | -$44.00K derived: sum of 3 quarters · filed 2026-08-06 | -$45.00K 10-K · filed 2026-03-02 |
| 2025-09-30 | $915.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $889.00K derived: sum of 2 quarters · filed 2026-08-06 | $888.00K 10-Q · filed 2025-11-06 | -$1.05M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$26.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$27.00K 10-Q · filed 2026-08-06 | -$1.97M derived: sum of 3 quarters · filed 2026-08-06 | -$1.83M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$1.00K 10-Q · filed 2026-05-07 | -$1.94M derived: sum of 2 quarters · filed 2026-05-07 | -$1.81M derived: sum of 3 quarters · filed 2026-05-07 | -$1.73M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$1.94M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$1.81M derived: sum of 2 quarters · filed 2026-03-02 | -$1.73M derived: sum of 3 quarters · filed 2026-03-02 | -$1.68M 10-K · filed 2026-03-02 |
| 2024-09-30 | $137.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $211.00K derived: sum of 2 quarters · filed 2025-11-06 | $261.00K 10-Q · filed 2025-11-06 | $1.24M derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-06-30 | $74.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $124.00K 10-Q · filed 2025-08-07 | $1.10M derived: sum of 3 quarters · filed 2026-03-02 | $776.00K derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-03-31 | $50.00K 10-Q · filed 2025-05-08 | $1.03M derived: sum of 2 quarters · filed 2026-03-02 | $702.00K derived: sum of 3 quarters · filed 2026-03-02 | $1.02M derived: sum of 4 quarters · filed 2026-03-02 |
| 2023-12-31 | $979.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $652.00K derived: sum of 2 quarters · filed 2026-03-02 | $970.00K derived: sum of 3 quarters · filed 2026-03-02 | $970.00K 10-K · filed 2026-03-02 |
| 2023-09-30 | -$327.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | -$9.00K derived: sum of 2 quarters · filed 2024-10-31 | -$9.00K 10-Q · filed 2024-10-31 | $831.00K derived: sum of 4 quarters · filed 2025-03-05 |
| 2023-06-30 | $318.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $318.00K 10-Q · filed 2024-08-01 | $1.16M derived: sum of 3 quarters · filed 2025-03-05 | $1.16M derived: sum of 4 quarters · filed 2025-03-05 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-02 | $840.00K derived: sum of 2 quarters · filed 2025-03-05 | $840.00K derived: sum of 3 quarters · filed 2025-03-05 | |
| 2022-12-31 | $840.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | $840.00K derived: sum of 2 quarters · filed 2025-03-05 | $840.00K 10-K · filed 2025-03-05 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $0.00 10-Q · filed 2023-11-07 | ||
| 2022-06-30 | $0.00 10-Q · filed 2023-08-10 | |||
| 2021-12-31 | $0.00 10-K · filed 2024-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |